AMH Biotech LLC is pleased to announce new research collaborations with the Sbarro Institute for Cancer Research at Temple University (Philadelphia, PA) and Rowan
University (New Jersey). These partnerships reflect AMH Biotech’s commitment to advancing innovative and translational science at the intersection of academia and biotechnology.
Through these collaborations, AMH Biotech will support interdisciplinary research efforts in cancer biology, precision medicine, and therapeutic target discovery. By combining AMH Biotech’s industry-driven translational focus with the deep scientific expertise and research infrastructure of its academic partners, these initiatives aim to accelerate the identification of novel cancer targets and enable the development of next-generation therapeutic strategies.
AMH Biotech LLC is proud to work alongside leading academic institutions to foster scientific innovation, train the next generation of researchers, and translate cutting-edge discoveries into meaningful clinical impact.
Ali Mohseni
AMH Biotech LLC
Founder & Principal Investigator
Email: drmohseni@amhbiotech.com
Website: www.amhbiotech.com
